Yüklüyor......

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly

PURPOSE: To report our findings in an infant with Peters anomaly type II whose retinopathy of prematurity (ROP) was treated with an anti-VEGF agent and surgeries. CASE REPORT: A male infant weighing 548 g was born prematurely at 23 weeks and 1 day with corneal opacity and shallow anterior chambers i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Case Rep Ophthalmol
Asıl Yazarlar: Minami, Tsuyoshi, Kuniyoshi, Kazuki, Kusaka, Shunji, Sugioka, Koji, Sakuramoto, Hiroyuki, Sakamoto, Masuo, Izu, Akane, Wada, Norihisa, Shimomura, Yoshikazu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224264/
https://ncbi.nlm.nih.gov/pubmed/25408672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368298
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!